INFLUENCE OF SEX, MENSTRUAL-CYCLE AND ORAL CONTRACEPTION ON THE DISPOSITION OF NITRAZEPAM

被引：86

作者：

JOCHEMSEN, R

VANDERGRAAFF, M

BOEIJINGA, JK

BREIMER, DD

机构：

来源：

关键词：

D O I：

10.1111/j.1365-2125.1982.tb01381.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：319 / 324

页数：6

共 21 条

[1] ABEL JG, 1979, CLIN PHARMACOL THER, V26, P247
[2] IMPAIRMENT OF ANTIPYRINE METABOLISM BY LOW-DOSE ORAL-CONTRACEPTIVE STEROIDS
ABERNETHY, DR
GREENBLATT, DJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (01) : 106 - 110
[3] BREIMER DD, 1980, ARZNEIMITTELFORSCH, V30-1, P875
[4] PLASMA-LEVEL PROFILE OF NITRAZEPAM (MOGADON) FOLLOWING ORAL-ADMINISTRATION
BREIMER, DD
BRACHT, H
DEBOER, AG
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (06) : 709 - 711
[5] CARTER DE, 1975, CLIN PHARMACOL THER, V18, P700
[6] CARTER DE, 1974, CLIN PHARMACOL THER, V15, P22
[7] de Boer A G, 1978, J Chromatogr, V145, P105, DOI 10.1016/S0378-4347(00)81672-2
[8] FIELD B, 1979, CLIN PHARMACOL THER, V25, P196
[9] INFLUENCE OF SEX ON DRUG KINETICS IN MAN
GIUDICELLI, JF
TILLEMENT, JP
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (03) : 157 - 166
[10] Goble F C, 1975, Adv Pharmacol Chemother, V13, P173, DOI 10.1016/S1054-3589(08)60232-X